Please assess the completion status of the following clinical trial:

Trial Title: Continuous Vs Single Shot Block After ACL

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of signed and dated informed consent form~* Stated willingness to comply with all study procedures and availability for the duration of the study~* Male or female, aged \>16 years old~* In good general health as evidenced by medical history and deemed medically healthy enough to tolerate surgery by the patient's primary care physician~* MRI with evidence of ACL tear, and wanting to have an ACL reconstruction surgery~* Ability to take oral medication and be willing to adhere to the study intervention, including telephone calls~* Agrees to complete surveys required on the days specified between 5-9PM~Exclusion Criteria:~* Current daily opioid requirement exceeding the equivalent of 15mg morphine~* Daily prescription of corticosteroid, tricyclic antidepressant, gabapentin, or tramadol~* Carrying the diagnosis of chronic pain syndrome, uncontrolled anxiety, history of schizophrenia or related psychiatric disorders~* History of alcohol or drug abuse/addiction~* History of preexisting nerve damage in the surgical extremity~* Knee surgery (same knee) in the previous 12 weeks~* Anticipated knee surgery in the other knee planned in the ensuing 6 months~* Diabetic patients with blood sugar values exceeding 250 mg/dl in the previous month~* BMI \>40Kg/m2~* Pregnancy, which will be determined by a serum or urine HCG test on the day of surgery.~* Incarceration~* Inability to communicate with staff, including being unreachable by telephone~* Revision ACL reconstruction~* Patient reconsideration after initial agreement.~* Non-English speaking subjects

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Single Shot (Type: ACTIVE_COMPARATOR): Patients will receive an adductor canal block in the operating room postoperatively as single shot of 20-30cc bupivacaine
- Continuous Block (Type: ACTIVE_COMPARATOR): Patients will have a catheter inserted into the adductor canal which will be attached up to a continuous infusion pump of bupivacaine that will have a set flow rate over the next couple days

Based on this trial design, predict the completion outcome and termination type (if applicable).